Investigating the role of complement 5a in systemic bone loss after myocardial infarction

Priscilla M Tjandra1, Sophie V Orr1, Selena K Lam1

  • 1University of California Davis, Department of Orthopaedic Surgery, United States of America.

Bone
|May 24, 2025
PubMed

Insights

Myocardial infarction (MI) causes bone loss, but complement 5a (C5a) may not be the primary driver of this systemic response. Further research is needed to clarify C5a's role in bone changes after MI.

Area of Science:

  • Cardiovascular Science
  • Bone Biology
  • Immunology

Background:

  • Myocardial infarction (MI) and osteoporotic fractures are leading causes of morbidity and mortality.
  • Previous studies linked MI to systemic bone loss, involving the sympathetic nervous system.
  • The systemic injury response after trauma involves multiple biological systems.

Purpose of the Study:

  • To investigate the role of complement 5a (C5a) in the systemic bone loss response following myocardial infarction (MI).
  • To analyze bone changes and osteoclast activity in mice with altered C5a signaling after MI.

Main Methods:

  • Surgical induction of MI in C57BL/6J, C5a receptor 1 knockout (C5aR1-/-), and C5-deficient B10·D2 mice.
  • Analysis of bone morphology using micro-computed tomography and mechanical testing at 7, 14, and 28 days post-MI.
  • Quantification of osteoclast activity and measurement of voluntary activity levels.

Main Results:

  • MI induced peak trabecular bone loss in the L5 vertebral body at 7 days and reduced femoral cortical bone at 28 days.
  • C5-deficient mice showed reduced bone morphology but no altered response to MI.
  • Osteoclast activity was increased in C5aR1-/- mice 7 days post-MI, but MI did not impact it.

Conclusions:

  • C5a may influence overall response to MI and bone morphology, rather than being the primary driver of post-traumatic bone loss.
  • The findings suggest C5a's role in post-MI bone changes is not a primary mechanism.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
46
Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
2.9K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
39
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
55
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
70